Braxford Journal

Meticulously accurate unadulterated publications

Nutraceuticals

This page is a work in progress.

Table of contents

Introduction

Welcome to the master list of natural cures for all diseases and illnesses. This is a short list, destined to become huge over time. My goal: A fully collective list.

Within this document you will find a safety rating, from A+ (the best) to F. Here is a breakdown:

RatingDescription
A+No negative debilitations or adverse affects.
ANo negative debilitations; some minor adverse affects.
BNo negative debilitations; some moderate adverse affects.
CPossible negative debilitations, strong adverse affects, and/or contradictory studies.

Common ailments

See below for a list of the most commonly searched diseases and potential cures.

Cancer

Coming soon…

Cardiovascular disease (CVD)

Coming soon…

Obesity

Obesity is a complex health condition characterized by an excessive accumulation of body fat, which can negatively impact overall health. It is typically measured using the Body Mass Index (BMI), with a BMI of 30 or higher classified as obese.

The following nutraceuticals have shown some positive effects on obesity:

Berberine

Berberine is a bioactive compound derived from several plants, including Berberis vulgaris (barberry), and has a rich history in traditional medicine. Berberine has been used for centuries in traditional Chinese and Ayurvedic medicine. It was primarily utilized for its antimicrobial, anti-inflammatory, and digestive health benefits. Ancient texts document its use for treating infections, gastrointestinal disorders, and as a general tonic.

In recent years, berberine has gained attention in the scientific community for its potential health benefits. Studies have shown that it may help regulate blood sugar levels, improve lipid profiles, and support weight loss. Berberine is known to activate AMPK (AMP-activated protein kinase), which plays a crucial role in cellular energy homeostasis and metabolism. Today, berberine is widely available as a dietary supplement, often marketed for its effects on metabolic health and cardiovascular support.

  • Can improve:
    • gout [ i ]
    • gut microbiota disorders [ i ]
    • Helicobacter pylori infections [ b ]
    • hyperlipidemia [ a | i ]
    • non-alcoholic fatty liver disease [ i ]
    • obesity [ a | h | i ]
    • type Ⅱ diabetes [ a | f | h | i ]
  • Can prevent:
    • prevent diabetic encephalopathy [ a ]
  • Reduces:
    • 2-h plasma blood glucose (2hPBG) [ c | g ]
    • body mass index (BMI) [ e | g ]
    • body weight [ e | h ]
    • C-reactive protein (CRP) concentrations [ e ]
    • fasting blood insulin (FINS) [ g ]
    • fasting plasma glucose (FPG) [ c | f | g ]
    • glycosylated hemoglobin (HbA1c) [ c | f | g ]
    • homeostasis model assessment-insulin resistance (HOMA-IR) [ g ]
    • insulin resistance [ a | g ]
    • low-density lipoprotein (LDL) [ a | g ]
    • total cholesterol (TC) [ a | d | g ]
    • triglycerides (TG) [ a | g | h ]
    • waist circumference [ e ]
  • Increases:
    • high-density lipoprotein (HDL) [ a | g ]
  • Side-effects:
    • constipation [ b ]
    • diarrhea [ b ]
  • Safety profile (A):
    • Safe [ a | c | e | f ]

Plant sterols and stanols

Plant sterols and stanols are natural compounds found in various plant-based foods that resemble cholesterol in structure. They are primarily derived from vegetable oils, nuts, seeds, and whole grains. These compounds are known for their cholesterol-lowering properties, as they can inhibit the absorption of dietary cholesterol in the intestines.

  • Can improve:
  • Can prevent:
  • Reduces:
    • low-density lipoprotein (LDL) [ a | b | c | d | e | g ]
    • fasting plasma glucose levels [ a ]
    • total cholesterol (TC) [ a | e | g ]
    • atherosclerotic lesion development | atherosclerotic risk [ c ]
  • Increases:
  • Side-effects:
  • Safety profile (C):
    • Safe [ f ]
    • Negative
      • a link between elevated plasma concentrations of circulating plant sterols with CVD presence [ a ]
      • a potential role in the development of non-alcoholic steatohepatitis (NASH), cardiovascular disease (CVD), inflammatory bowel diseases (IBD) and allergic asthma [ c ]